[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-1785":3,"doc-seo-1785":26},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":19,"is_downloadable":19,"audit_status":19,"page_count":20,"language":21,"language_code":22,"table_of_contents":23,"faqs":23,"seo_title":13,"seo_description":14,"update_tm":24,"read_time":25},1785,1099514067438,"River Wang","https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc",8,"Research & Report","Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591","Phase I dose-escalation study evaluated safety and preliminary efficacy of the alpha-emitting PSMA-targeted monoclonal antibody 225Ac-J591 in metastatic castration-resistant prostate cancer. A single dose of 225Ac-J591 showed no acute dose-limiting toxicity. Prostate-specific antigen decline and circulating tumor cell count control demonstrated preliminary efficacy, including patients with or without prior 177Lu-PSMA.","cbCaiglIT8U50WB1","https://ap.wps.com/l/cbCaiglIT8U50WB1","pdf",847537,1,15,"English","en","",1776249046,38,{"code":4,"msg":27,"data":28},"ok",{"site_id":29,"language":22,"slug":30,"title":13,"keywords":23,"description":14,"schema_data":31,"social_meta":66,"head_meta":69,"extra_data":71,"updated_unix":24},105,"prostate-specific-membrane-antigentargeting-alpha-emitter-via-antibody-delivery-for-metastatic-castration-resistant-prostate-cancer-a-phase-i-dose-escalation-study-of-225ac-j591",{"@graph":32,"@context":65},[33,50],{"@type":34,"itemListElement":35},"BreadcrumbList",[36,40,44,47],{"item":37,"name":38,"@type":39,"position":19},"https://docshare.wps.com","Home","ListItem",{"item":41,"name":42,"@type":39,"position":43},"https://docshare.wps.com/document/","Document",2,{"item":45,"name":12,"@type":39,"position":46},"https://docshare.wps.com/document/research-report/",3,{"item":48,"name":13,"@type":39,"position":49},"https://docshare.wps.com/document/prostate-specific-membrane-antigentargeting-alpha-emitter-via-antibody-delivery-for-metastatic-castration-resistant-prostate-cancer-a-phase-i-dose-escalation-study-of-225ac-j591/1785/",4,{"url":48,"name":13,"@type":51,"author":52,"headline":13,"publisher":54,"fileFormat":57,"description":14,"dateModified":58,"datePublished":59,"encodingFormat":57,"isAccessibleForFree":60,"interactionStatistic":61},"DigitalDocument",{"name":9,"@type":53},"Person",{"url":37,"name":55,"@type":56},"DocShare","Organization","application/pdf","2026-05-22","2026-04-15",true,{"@type":62,"interactionType":63,"userInteractionCount":19},"InteractionCounter",{"@type":64},"ViewAction","https://schema.org",{"og:url":67,"og:type":68,"og:title":13,"og:site_name":55,"og:description":14},"https://docshare.wps.com/document/prostate-specific-membrane-antigentargeting-alpha-emitter-via-antibody-delivery-for-metastatic-castration-resistant-prostate-cancer-a-phase-i-dose-escalation-study-of-225ac-j591/1785","article",{"robots":70,"canonical":67},"index,follow",{"doc_id":7,"site_id":29}]